HK1034263A1 - 7-alpha-methyl 19-nortestosterone undecanoate with androgenic activity - Google Patents

7-alpha-methyl 19-nortestosterone undecanoate with androgenic activity

Info

Publication number
HK1034263A1
HK1034263A1 HK01104759A HK01104759A HK1034263A1 HK 1034263 A1 HK1034263 A1 HK 1034263A1 HK 01104759 A HK01104759 A HK 01104759A HK 01104759 A HK01104759 A HK 01104759A HK 1034263 A1 HK1034263 A1 HK 1034263A1
Authority
HK
Hong Kong
Prior art keywords
methyl
undecanoate
nortestosterone
alpha
androgenic activity
Prior art date
Application number
HK01104759A
Other languages
English (en)
Inventor
Dirk Leysen
Voort Hendrikus Adrianus A Der
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HK1034263A1 publication Critical patent/HK1034263A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK01104759A 1998-06-19 2001-07-10 7-alpha-methyl 19-nortestosterone undecanoate with androgenic activity HK1034263A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202052 1998-06-19
PCT/EP1999/004102 WO1999067271A1 (en) 1998-06-19 1999-06-14 Testosterone derivative

Publications (1)

Publication Number Publication Date
HK1034263A1 true HK1034263A1 (en) 2001-10-19

Family

ID=8233831

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104759A HK1034263A1 (en) 1998-06-19 2001-07-10 7-alpha-methyl 19-nortestosterone undecanoate with androgenic activity

Country Status (26)

Country Link
US (3) US6437158B1 (xx)
EP (1) EP1087986B1 (xx)
JP (1) JP2002518514A (xx)
KR (1) KR100596649B1 (xx)
CN (1) CN1172949C (xx)
AT (1) ATE215961T1 (xx)
AU (1) AU756739B2 (xx)
BR (1) BR9911344A (xx)
CA (1) CA2333985C (xx)
CZ (1) CZ293319B6 (xx)
DE (1) DE69901250T2 (xx)
DK (1) DK1087986T3 (xx)
ES (1) ES2175989T3 (xx)
HK (1) HK1034263A1 (xx)
HU (1) HUP0102274A3 (xx)
ID (1) ID27260A (xx)
IL (1) IL139689A (xx)
NO (1) NO316518B1 (xx)
NZ (1) NZ508299A (xx)
PL (1) PL191285B1 (xx)
PT (1) PT1087986E (xx)
RU (1) RU2216546C2 (xx)
SK (1) SK282796B6 (xx)
TR (1) TR200003743T2 (xx)
WO (1) WO1999067271A1 (xx)
ZA (1) ZA200006813B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
ATE294812T1 (de) * 2000-07-28 2005-05-15 Akzo Nobel Nv 16alpha-methyl oder ethyl substituierte oestrogene
JP3774888B2 (ja) * 2001-11-28 2006-05-17 日本化薬株式会社 ステロイド類化合物のｌｃ−ｍｓによる高感度検出法
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP1879382B1 (en) 2006-07-10 2017-09-06 Samsung Electronics Co., Ltd. Multi-screen display apparatus and method for digital broadcast receiver
WO2008101030A1 (en) * 2007-02-13 2008-08-21 The Regents Of The University Of California Methods for amplifying steroid hormone effects
US20090017107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase libido
US20090018107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase muscle strength
US20100303937A1 (en) * 2009-06-01 2010-12-02 Michael Farber Novel composition to increase testosterone levels
CN102558267A (zh) * 2012-01-13 2012-07-11 宜城市共同药业有限公司 庚酸睾酮的制备方法
CN104487114A (zh) * 2012-04-06 2015-04-01 安塔雷斯药品公司 针头辅助喷射注射给予睾酮组合物
EP2953667B1 (en) 2013-02-11 2019-10-23 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation

Also Published As

Publication number Publication date
IL139689A0 (en) 2002-02-10
AU4610199A (en) 2000-01-10
NO316518B1 (no) 2004-02-02
SK282796B6 (sk) 2002-12-03
RU2216546C2 (ru) 2003-11-20
US6437158B1 (en) 2002-08-20
KR20010052850A (ko) 2001-06-25
BR9911344A (pt) 2001-03-13
CZ20004779A3 (en) 2001-06-13
AU756739B2 (en) 2003-01-23
NO20006455L (no) 2000-12-18
WO1999067271A1 (en) 1999-12-29
DK1087986T3 (da) 2002-06-17
KR100596649B1 (ko) 2006-07-06
SK19402000A3 (sk) 2001-07-10
US20040033999A1 (en) 2004-02-19
ATE215961T1 (de) 2002-04-15
JP2002518514A (ja) 2002-06-25
CA2333985A1 (en) 1999-12-29
HUP0102274A3 (en) 2002-08-28
HUP0102274A2 (hu) 2001-12-28
ES2175989T3 (es) 2002-11-16
CN1172949C (zh) 2004-10-27
US6989378B2 (en) 2006-01-24
EP1087986B1 (en) 2002-04-10
PT1087986E (pt) 2002-08-30
PL344987A1 (en) 2001-11-19
TR200003743T2 (tr) 2001-07-23
NO20006455D0 (no) 2000-12-18
DE69901250D1 (de) 2002-05-16
ZA200006813B (en) 2002-02-21
CN1305488A (zh) 2001-07-25
IL139689A (en) 2004-09-27
CA2333985C (en) 2007-04-10
CZ293319B6 (cs) 2004-04-14
DE69901250T2 (de) 2002-10-17
EP1087986A1 (en) 2001-04-04
US20050153949A1 (en) 2005-07-14
ID27260A (id) 2001-03-22
NZ508299A (en) 2003-04-29
PL191285B1 (pl) 2006-04-28

Similar Documents

Publication Publication Date Title
HK1034263A1 (en) 7-alpha-methyl 19-nortestosterone undecanoate with androgenic activity
IL148288A0 (en) Indolealkanol ester and indolealkylamide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
GR3031126T3 (en) Taxol derivatives.
HK1082258A1 (en) Oestrogen derivatives as inhibitors of steroid sulphatase
AU2182001A (en) Catalysts for hydrosilylation reactions
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
AU2610699A (en) Derivatives of glp-1 analogs
ZA976705B (en) Process for the synthesis of protected esters of (S)-3,4-dihydroxybutric acid.
HK1046639A1 (en) Nitroimidazole external preparations for dermatosis
EP1042352A4 (en) ANDROGENIC STEROID COMPOUNDS AND METHOD OF MANUFACTURE AND USE THEREOF
AU2003279624A1 (en) Synthesis of estetrol via estrone derived steroids
SI0934065T1 (sl) Novi kriptoficinski derivati kot anti-neoplasticna sredstva
ES2154560A1 (es) Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
HK1063052A1 (en) A process for the preparation of paclitaxel
ZA9811380B (xx)
MX207081B (xx)
HK1048338A1 (en) A process for the preparation of derivatives of ruscus aculeatus steroid glycosides by enzymatic hydrolysis.
DK1107751T3 (da) Lægemiddel indeholdende platinkompleksforbindelser samt anvendelse deraf
AU1549001A (en) Remedies for periodontosis
IL150082A0 (en) Unsaturated 14, 15-cyclopropane-andostranes, a method for their production and pharmaceutical compositions containing these compounds
MY120189A (en) Sultam and sultone derived oxazolidinones
AU2507501A (en) 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds
ECSP992934A (es) Procedimiento mejorado para la preparacion de derivados de norbenzomorfano, valiosos farmaceuticamente

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090614